AVITA Medical Inc.

NASDAQ: RCEL · Real-Time Price · USD
5.62
-0.18 (-3.10%)
At close: Aug 15, 2025, 3:59 PM
5.74
2.14%
After-hours: Aug 15, 2025, 04:31 PM EDT

AVITA Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
18.42M 18.51M 18.41M 19.55M 15.2M 11.1M 14.2M 21.23M 17.65M 10.55M 9.46M 14.22M 12.07M 10.07M 9.55M 7.02M 10.3M 11.54M
Cost of Revenue
3.47M 2.83M 2.28M 3.19M 2.11M 1.51M 1.8M 3.29M 3.31M 2.49M 1.98M 2.39M 2.01M 2.38M 1.12M 1.09M 2.05M 2.83M
Gross Profit
14.95M 15.68M 16.13M 16.36M 13.08M 9.59M 12.4M 17.94M 14.34M 13.29M 11.91M 11.82M 10.06M 7.7M 8.42M 5.93M 8.25M 8.71M
Operating Income
-11.15M -11.83M -9.96M -13.81M -15.62M -17.21M -12.27M -14.35M -16.76M -14.82M -8.68M -8.99M -9.21M -12.68M -11.6M -5.95M -4.7M -7.89M
Interest Income
n/a n/a n/a n/a n/a n/a n/a 15.56K 10.51K 5.98K 8.81K 9.38K 5.79K 12.45K 11.01K n/a n/a 3.95K
Pretax Income
-9.92M -13.85M -11.57M -16.23M -15.36M -18.63M -7.05M -13.54M -15.57M -13.75M -7.83M -8.73M -9.06M -12.64M -11.64M -5.94M -4.71M -7.88M
Net Income
-9.92M -13.86M -11.59M -16.2M -15.39M -18.66M -7.07M -13.55M -15.59M -13.79M -7.86M -8.74M -9.07M -12.65M -11.67M -5.95M -4.72M -7.9M
Selling & General & Admin
20.98M 21.22M 21.23M 24.73M 23.82M 21.6M 17.97M 25.78M 15.95M 14.84M 17.13M 16.28M 10.6M 12.15M 14.53M 8.87M 9.42M 8.87M
Research & Development
5.12M 6.28M 4.85M 5.43M 4.89M 5.19M 6.76M 6.84M 7.62M 6.86M 4.96M 5.94M 4.43M 4.84M 5.78M 3.39M 3.97M 5.41M
Other Expenses
n/a n/a n/a n/a n/a n/a -59K n/a n/a n/a n/a n/a n/a n/a n/a 16K 2K n/a
Operating Expenses
26.1M 27.51M 26.08M 30.16M 28.71M 26.8M 24.67M 31.46M 29.9M 27.03M 19.73M 20.54M 19.12M 20.33M 20.05M 11.88M 12.96M 16.59M
Interest Expense
1.25M 1.23M 1.3M 1.36M 1.35M 1.36M 1.12M n/a n/a n/a n/a n/a n/a n/a n/a 9K 9K n/a
Selling & Marketing Expenses
14.31M 14.83M 14.11M 15.14M 16.3M 12.64M 10.22M 16.38M 9.79M 6.54M 9.32M 8.46M 5.33M 4.83M 6.82M 3.52M 4.15M 3.65M
Cost & Expenses
29.57M 30.34M 28.36M 33.35M 30.82M 28.31M 26.47M 34.75M 33.21M 29.52M 21.71M 22.94M 21.13M 22.7M 21.18M 12.97M 15.01M 19.42M
Income Tax Expense
4K 8K 19K -28K 33K 30K 12K 17.11K 19.52K 44.87K 35.25K 6.25K 5.79K 5.35K 26.15K 6K 7K 13.16K
Shares Outstanding (Basic)
26.37M 26.25M 26.15M 25.98M 25.76M 25.64M 25.48M 25.4M 25.24M 25.2M 25.08M 25.01M 24.97M 24.94M 24.93M 24.91M 24.86M 22.73M
Shares Outstanding (Diluted)
26.37M 26.25M 26.15M 25.98M 25.76M 25.64M 25.48M 25.4M 25.24M 25.2M 25.08M 25.01M 24.97M 24.94M 24.93M 24.91M 24.86M 22.73M
EPS (Basic)
-0.38 -0.53 -0.44 -0.62 -0.6 -0.73 -0.28 -0.53 -0.62 -0.55 -0.31 -0.35 -0.36 -0.51 -0.47 -0.24 -0.19 -0.35
EPS (Diluted)
-0.38 -0.53 -0.44 -0.62 -0.6 -0.73 -0.28 -0.53 -0.62 -0.55 -0.31 -0.35 -0.36 -0.51 -0.47 -0.24 -0.19 -0.35
EBITDA
-8.11M -12.1M -9.86M -14.56M -13.81M -17.07M -5.44M -14.09M -16.54M -14.62M -8.49M -8.77M -9.02M -12.46M -11.39M -5.93M -4.7M -7.67M
EBIT
-8.66M -12.62M -10.27M -14.87M -14.01M -17.27M -5.93M -14.35M -16.76M n/a n/a n/a -9.21M n/a n/a n/a n/a -7.89M
Depreciation & Amortization
552K 521K 409K 310K 204K 203K 187K 164K 146K 860K 715K 308K 246K 28K 22K 174K 175K 167K